Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
暂无分享,去创建一个
S. Boyce | T. Zollner | M. Gemkow | J. Nagel | S. D. Hess | I. Neagoe | Adam J. Davenport | O. Fischer | A. Coelho | A. Rotgeri | A. Laux-Biehlmann | M. Koch | Nico Bräuer | F. Machet | N. Carty | Adam J Davenport